RxDoctor Payments Data

Michael Didinsky, DO

Orthopaedic Surgery of the Spine · Kenosha, WINPI 1316928336

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $143,646 of the $157,097 with a category attached, or 91.4%. Globus Medical accounts for 92.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $49,142 and has fallen 97.8% since, to $1,101 in 2025.

$157,097in general payments, 2019–2025

Across 166 payments — averaging $946.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$146K
  • Stryker$6K
  • Cerapedics Inc.$3K
  • Medtronic$2K
  • Siemens Medical Solutions USA, Inc.$355
  • Nevro Corp.$42
  • plus $187 from 8 others

What the payments were for

  • Royalty or licence$143,64691%
  • Travel & lodging$6,0194%
  • Food & beverage$7,4325%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic surgery of the spine providers in Wisconsinto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$132,371
Medicare patients
309
Services billed
930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib14$910
Naproxen60$491
Methylprednisolone48$307
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen17$244
Diclofenac Sodium13$207
Tramadol Hcl12$39
Cephalexin11$32

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Kenosha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →